678 related articles for article (PubMed ID: 30912920)
1. Surface-Functionalized Modified Copper Sulfide Nanoparticles Enhance Checkpoint Blockade Tumor Immunotherapy by Photothermal Therapy and Antigen Capturing.
Wang R; He Z; Cai P; Zhao Y; Gao L; Yang W; Zhao Y; Gao X; Gao F
ACS Appl Mater Interfaces; 2019 Apr; 11(15):13964-13972. PubMed ID: 30912920
[TBL] [Abstract][Full Text] [Related]
2. Light-triggered OVA release based on CuS@poly(lactide-co-glycolide acid) nanoparticles for synergistic photothermal-immunotherapy of tumor.
Chen Z; Zhang Q; Zeng L; Zhang J; Liu Z; Zhang M; Zhang X; Xu H; Song H; Tao C
Pharmacol Res; 2020 Aug; 158():104902. PubMed ID: 32417504
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional nanoparticles precisely reprogram the tumor microenvironment and potentiate antitumor immunotherapy after near-infrared-II light-mediated photothermal therapy.
Ge Y; Zhang J; Jin K; Ye Z; Wang W; Zhou Z; Ye J
Acta Biomater; 2023 Sep; 167():551-563. PubMed ID: 37302731
[TBL] [Abstract][Full Text] [Related]
4. Photothermally activatable PDA immune nanomedicine combined with PD-L1 checkpoint blockade for antimetastatic cancer photoimmunotherapy.
Lu Q; Qi S; Li P; Yang L; Yang S; Wang Y; Cheng Y; Song Y; Wang S; Tan F; Li N
J Mater Chem B; 2019 Apr; 7(15):2499-2511. PubMed ID: 32255127
[TBL] [Abstract][Full Text] [Related]
5. Nanoscale Reduced Graphene Oxide-Mediated Photothermal Therapy Together with IDO Inhibition and PD-L1 Blockade Synergistically Promote Antitumor Immunity.
Yan M; Liu Y; Zhu X; Wang X; Liu L; Sun H; Wang C; Kong D; Ma G
ACS Appl Mater Interfaces; 2019 Jan; 11(2):1876-1885. PubMed ID: 30582788
[TBL] [Abstract][Full Text] [Related]
6. Single agent nanoparticle for radiotherapy and radio-photothermal therapy in anaplastic thyroid cancer.
Zhou M; Chen Y; Adachi M; Wen X; Erwin B; Mawlawi O; Lai SY; Li C
Biomaterials; 2015 Jul; 57():41-9. PubMed ID: 25913249
[TBL] [Abstract][Full Text] [Related]
7. Copper sulfide nanoparticles with phospholipid-PEG coating for in vivo near-infrared photothermal cancer therapy.
Huang Y; Lai Y; Shi S; Hao S; Wei J; Chen X
Chem Asian J; 2015 Feb; 10(2):370-6. PubMed ID: 25425287
[TBL] [Abstract][Full Text] [Related]
8. Immune Checkpoint Blockade Mediated by a Small-Molecule Nanoinhibitor Targeting the PD-1/PD-L1 Pathway Synergizes with Photodynamic Therapy to Elicit Antitumor Immunity and Antimetastatic Effects on Breast Cancer.
Zhang R; Zhu Z; Lv H; Li F; Sun S; Li J; Lee CS
Small; 2019 Dec; 15(49):e1903881. PubMed ID: 31702880
[TBL] [Abstract][Full Text] [Related]
9. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
[TBL] [Abstract][Full Text] [Related]
10. Ataxia telangiectasia mutated inhibitor-loaded copper sulfide nanoparticles for low-temperature photothermal therapy of hepatocellular carcinoma.
Cai H; Dai X; Guo X; Zhang L; Cao K; Yan F; Ji B; Liu Y
Acta Biomater; 2021 Jun; 127():276-286. PubMed ID: 33812073
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional PEG-GO/CuS nanocomposites for near-infrared chemo-photothermal therapy.
Bai J; Liu Y; Jiang X
Biomaterials; 2014 Jul; 35(22):5805-13. PubMed ID: 24767788
[TBL] [Abstract][Full Text] [Related]
12. Antifouling Dendrimer-Entrapped Copper Sulfide Nanoparticles Enable Photoacoustic Imaging-Guided Targeted Combination Therapy of Tumors and Tumor Metastasis.
Ouyang Z; Li D; Xiong Z; Song C; Gao Y; Liu R; Shen M; Shi X
ACS Appl Mater Interfaces; 2021 Feb; 13(5):6069-6080. PubMed ID: 33501834
[TBL] [Abstract][Full Text] [Related]
13. Tumor-targeting CuS nanoparticles for multimodal imaging and guided photothermal therapy of lymph node metastasis.
Shi H; Yan R; Wu L; Sun Y; Liu S; Zhou Z; He J; Ye D
Acta Biomater; 2018 May; 72():256-265. PubMed ID: 29588255
[TBL] [Abstract][Full Text] [Related]
14. Light-Responsive Core-Shell Nanoplatform for Bimodal Imaging-Guided Photothermal Therapy-Primed Cancer Immunotherapy.
Zhang W; Zhang CC; Wang XY; Li L; Chen QQ; Liu WW; Cao Y; Ran HT
ACS Appl Mater Interfaces; 2020 Oct; 12(43):48420-48431. PubMed ID: 33073973
[TBL] [Abstract][Full Text] [Related]
15. Cetuximab-modified CuS nanoparticles integrating near-infrared-II-responsive photothermal therapy and anti-vessel treatment.
Li B; Jiang Z; Xie D; Wang Y; Lao X
Int J Nanomedicine; 2018; 13():7289-7302. PubMed ID: 30510418
[TBL] [Abstract][Full Text] [Related]
16. PEGylated reduced-graphene oxide hybridized with Fe
Wang L; Wang M; Zhou B; Zhou F; Murray C; Towner RA; Smith N; Saunders D; Xie G; Chen WR
J Mater Chem B; 2019 Dec; 7(46):7406-7414. PubMed ID: 31710067
[TBL] [Abstract][Full Text] [Related]
17. Tailor-made PEG-DA-CuS nanoparticles enriched in tumor with the aid of retro Diels-Alder reaction triggered by their intrinsic photothermal property.
Sheng J; Ma B; Yang Q; Zhang C; Jiang Z; Borrathybay E
Int J Nanomedicine; 2018; 13():4291-4302. PubMed ID: 30087561
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a nanocomposite of PEG-curcumin-gold nanoparticles as a near-infrared photothermal agent: an in vitro and animal model investigation.
Rahimi-Moghaddam F; Azarpira N; Sattarahmady N
Lasers Med Sci; 2018 Nov; 33(8):1769-1779. PubMed ID: 29790012
[TBL] [Abstract][Full Text] [Related]
19. Synergistic photothermal cancer immunotherapy by Cas9 ribonucleoprotein-based copper sulfide nanotherapeutic platform targeting PTPN2.
Yan T; Yang K; Chen C; Zhou Z; Shen P; Jia Y; Xue Y; Zhang Z; Shen X; Han X
Biomaterials; 2021 Dec; 279():121233. PubMed ID: 34749073
[TBL] [Abstract][Full Text] [Related]
20. Rationally designed peptide-conjugated gold/platinum nanosystem with active tumor-targeting for enhancing tumor photothermal-immunotherapy.
Yang Q; Peng J; Shi K; Xiao Y; Liu Q; Han R; Wei X; Qian Z
J Control Release; 2019 Aug; 308():29-43. PubMed ID: 31252039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
